Neuron-D
Neuron-D
  • Main
  • About us
    • Our Team
    • Our Partners
    • Our Business Model
  • Our Science
    • History
    • Unique 3D Approach
    • Patented Technology
    • Scientific Publications
  • Our products
    • 3D Alzheimer's & TAUpathy
    • 3D Brain Development
    • 3D Toxicity
    • 3D Glioblastoma ex vivo
    • 3D Customizable Products
  • Our facilities
  • Proprietary Rights
  • News
  • More
    • Main
    • About us
      • Our Team
      • Our Partners
      • Our Business Model
    • Our Science
      • History
      • Unique 3D Approach
      • Patented Technology
      • Scientific Publications
    • Our products
      • 3D Alzheimer's & TAUpathy
      • 3D Brain Development
      • 3D Toxicity
      • 3D Glioblastoma ex vivo
      • 3D Customizable Products
    • Our facilities
    • Proprietary Rights
    • News
  • Main
  • About us
    • Our Team
    • Our Partners
    • Our Business Model
  • Our Science
    • History
    • Unique 3D Approach
    • Patented Technology
    • Scientific Publications
  • Our products
    • 3D Alzheimer's & TAUpathy
    • 3D Brain Development
    • 3D Toxicity
    • 3D Glioblastoma ex vivo
    • 3D Customizable Products
  • Our facilities
  • Proprietary Rights
  • News

Our team

Our team is a unique combination of scientists and business executives culminating innovative ideas and perfect scientific execution with sustainable financial stability and R&D capacity. We place great importance on R&D to dynamically match the needs of our customers.

Ozgur Delikanli

Prof. Dr. Carsten Werner

Prof. Dr. Caghan Kizil

Co-founder, Chief Executive Officer


Ozgur Delikanli is a New York-based entrepreneur, businessman and investor. He holds B.S. in Engineering and M.A. Economics degrees. Ozgur believes that future is in life sciences. He is using his business  expertise to oversee Neuron D’s business and business development models. He is constantly searchi

Co-founder, Chief Executive Officer


Ozgur Delikanli is a New York-based entrepreneur, businessman and investor. He holds B.S. in Engineering and M.A. Economics degrees. Ozgur believes that future is in life sciences. He is using his business  expertise to oversee Neuron D’s business and business development models. He is constantly searching and communicating with new markets and innovative approaches.  

Read more

Prof. Dr. Caghan Kizil

Prof. Dr. Carsten Werner

Prof. Dr. Caghan Kizil

Co-founder, Scientific Advisor, Neuroscience


Caghan Kizil is a geneticist and neuroscientist. He is an Associate Professor at Columbia University Irving Medical Center, New York, USA., He was the founding CEO of Neuron D from 2019 to 2022. 

Kizil Lab website

Prof. Dr. Carsten Werner

Prof. Dr. Carsten Werner

Prof. Dr. Carsten Werner

Co-founder, Scientific Advisor, Material Sciences


Carsten Werner is a professor for Biofunctional Polymer Materials at the Technische Universität Dresden, Center for Regenerative Therapies Dresden and directs the Biomaterials program at the Leibniz Institute of Polymer Research Dresden/Max Bergmann Center of Biomaterials Dresden (Germany).

Co-founder, Scientific Advisor, Material Sciences


Carsten Werner is a professor for Biofunctional Polymer Materials at the Technische Universität Dresden, Center for Regenerative Therapies Dresden and directs the Biomaterials program at the Leibniz Institute of Polymer Research Dresden/Max Bergmann Center of Biomaterials Dresden (Germany). His research aims at recapitulating functionalities of living matter in engineered polymer materials and includes studies on electrosurface phenomena, hemocompatibility of biomaterials and cell-instructive materials platforms for regenerative therapies and tissue models.

Werner Lab website

Dr. Uwe Freudenberg

Dr. Stanislava Popova

Prof. Dr. Carsten Werner

Co-founder


Uwe Freudenberg is a group leader for Matrix Engineering at the Institute of Biofunctional Polymer Materials at the Leibniz Institute of Polymer Research Dresden, Germany (IPF). He received his doctoral degree (Dr.-Ing.) from the Faculty of Mechanical Science and Engineering at the Technische Universität Dresden in 2007. His cur

Co-founder


Uwe Freudenberg is a group leader for Matrix Engineering at the Institute of Biofunctional Polymer Materials at the Leibniz Institute of Polymer Research Dresden, Germany (IPF). He received his doctoral degree (Dr.-Ing.) from the Faculty of Mechanical Science and Engineering at the Technische Universität Dresden in 2007. His current research focuses on the development of multifunctional polymer materials for biomedical applications with special emphasis on GAG-based hydrogels.

...

Freudenberg website @ IPF

Dr. Stanislava Popova

Dr. Stanislava Popova

Dr. Stanislava Popova

R&D Associate, Neuroscience


Stanislava  Popova received her PhD degree from the Faculty of Medicine  "Carl Gustav Carus" at the Technische Universität Dresden and performed her postdoctoral research in German Center for Neurodegenerative Diseases (DZNE). Her expertise includes gene silencing, genomic engineering, recombinant technologies, 

R&D Associate, Neuroscience


Stanislava  Popova received her PhD degree from the Faculty of Medicine  "Carl Gustav Carus" at the Technische Universität Dresden and performed her postdoctoral research in German Center for Neurodegenerative Diseases (DZNE). Her expertise includes gene silencing, genomic engineering, recombinant technologies, 3D hydrogel cultures, cell-based metabolic assays, animal models of disease, and high-throughput assay automation and optimization.  

...

Dr. Rajvinder Kaur

Dr. Stanislava Popova

Dr. Stanislava Popova

R&D Associate, Neuroscience


Rajvinder Kaur is a neurobiologist, received her Ph.D. degree from the Faculty of Biology at the Technische Universität Darmstadt, Germany. Her cross-disciplinary research expertise includes pharmacological modulators and ionizing radiation, neuronal activity and plasticity, 2D and 3D mammalian cell culture syst

R&D Associate, Neuroscience


Rajvinder Kaur is a neurobiologist, received her Ph.D. degree from the Faculty of Biology at the Technische Universität Darmstadt, Germany. Her cross-disciplinary research expertise includes pharmacological modulators and ionizing radiation, neuronal activity and plasticity, 2D and 3D mammalian cell culture systems, stem cell differentiation, cell-based  biochemical assays, array-based extracellular recordings, animal research, and imaging. 

Dr. Bengisu Turgutalp

Dr. Bengisu Turgutalp

Dr. Bengisu Turgutalp

R&D Associate, Pharmacology


Bengisu  Turgutalp is a pharmacist and medicinal chemist, received her Ph.D. from the Institute of Health Sciences at Yeditepe University, and performed post-doctoral research in German Center for Neurodegenerative Diseases (DZNE). Her expertise includes design and synthesis of  pharmacologically active compound

R&D Associate, Pharmacology


Bengisu  Turgutalp is a pharmacist and medicinal chemist, received her Ph.D. from the Institute of Health Sciences at Yeditepe University, and performed post-doctoral research in German Center for Neurodegenerative Diseases (DZNE). Her expertise includes design and synthesis of  pharmacologically active compounds, physicochemical characterization of  newly synthesized compounds, structure-activity relationship studies, in vitro pharmacokinetics profiling and in vivo pre-clinical animal studies.

Dr. Nicholas Dennison

Dr. Bengisu Turgutalp

Dr. Bengisu Turgutalp

R&D Associate, Engineering


Nicholas Dennison is a researcher at the Faculty of Chemistry, Technische Universität Dresden and Institute of  Biofunctional Polymer Materials at the Leibniz Institute of Polymer Research Dresden, Germany (IPF). His expertise includes high-throughput screening automation for biological assays,  high-content imag

R&D Associate, Engineering


Nicholas Dennison is a researcher at the Faculty of Chemistry, Technische Universität Dresden and Institute of  Biofunctional Polymer Materials at the Leibniz Institute of Polymer Research Dresden, Germany (IPF). His expertise includes high-throughput screening automation for biological assays,  high-content imaging and analysis, Design-of-experiment tools (DOE), hydrogel design for 3D cell cultures and compound screenings on in vitro tissue models.

Ezgi Eris

Dr. Bengisu Turgutalp

Dr. Nambirajan Govindarajan

Market Strategy Consultant


Ezgi Eris has over 10 years of pharmaceutical experience in medical strategy development, KOL relationship management, medical projects, clinical research, and drug safety. She was a hematology/ oncology MSL at Celgene for 9 years. She later served within the business strategy department of a healthcare agency th

Market Strategy Consultant


Ezgi Eris has over 10 years of pharmaceutical experience in medical strategy development, KOL relationship management, medical projects, clinical research, and drug safety. She was a hematology/ oncology MSL at Celgene for 9 years. She later served within the business strategy department of a healthcare agency that focuses on developing promotional materials in the area of neurological diseases. 

Dr. Nambirajan Govindarajan

Dr. Nambirajan Govindarajan

Dr. Nambirajan Govindarajan

Strategic Advisor

  

Dr. N. Govindarajan works as Research and Innovation Manager at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, bridging the fields of Artificial Intelligence and Life Sciences. Govind brings to our team his decade-long research experience in neurodegeneration along with many years of work experience in

Strategic Advisor

  

Dr. N. Govindarajan works as Research and Innovation Manager at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, bridging the fields of Artificial Intelligence and Life Sciences. Govind brings to our team his decade-long research experience in neurodegeneration along with many years of work experience in grants consultancy, R&D, and business strategies to ensure our lasting impact on the drug development technology landscape. 

Connect With Us


Copyright © 2022  All Rights Reserved Neuron D GmbH

  • Privacy policy
  • Impressum
  • Contact Us

Powered by Website Builder

3D Glioblastoma ex vivo

We are excited to launch our 3D model of human Glioblastoma multiforme, one of the most aggressive tumors of our brains. 

Learn more

Cookie Policy

This website uses cookies. Cookie policies and information can be found under Privacy Policy. You can continue to the website after making your choice. 

DeclineAccept